379
Views
16
CrossRef citations to date
0
Altmetric
Articles

Protective effects of salusin-α and salusin-β on renal ischemia/reperfusion damage and their levels in ischemic acute renal failure

, , , &
Pages 122-133 | Accepted 12 Jan 2017, Published online: 06 Mar 2017

References

  • Aebi H (1974) Catalase. In: Bergmeyer HU, Ed. Methods of Enzymatic Analysis. Academic Press. New York. pp. 673–677.
  • Ahmadiasl N, Banaei S, Alihemati A, Baradaran B, Azimian E (2014) Effect of a combined treatment with erythropoietin and melatonin on renal ischemia re-perfusion injury in male rats. Clin. Exp. Nephrol. 18: 855–864.
  • Akcay A, Nguyen Q, Edelstein CL (2009) Mediators of inflammation in acute kidney injury. Mediat. Inflam. 2009: 137072.
  • Aydin S, Aydin S (2014) Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome. Biotech. & Histochem. 89: 98–103.
  • Bircan B, Çakir M, Kirbağ S, Gül HF (2016) Effect of apelin hormone on renal ischemia/re-perfusion induced oxidative damage in rats. Ren. Fail. 19: 1–7.
  • Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121: 4210–4221.
  • Bucuvic EM, Ponce D, Balbi AL (2011) Risk factors for mortality in acute kidney injury. Rev. Assoc. Med. Bras. 57: 158–163.
  • Cakir M, Polat A, Tekin S, Vardi N, Taslidere E, Rumeysa Duran Z, Tanbek K (2015) The effect of dexmedetomidine against oxidative and tubular damage induced by renal ischemia re-perfusion in rats. Ren. Fail. 37: 704–708.
  • Citil C, Konar V, Aydin S, Yilmaz M, Albayrak S, Ozercan IH, Ozkan Y (2014) Brain, liver, and serum salusin-alpha and -beta alterations in Sprague-Dawley rats with or without metabolic syndrome. Med. Sci. Monit. 29: 1326–1333.
  • Collino M, Rogazzo M, Pini A, Benetti E, Rosa AC, Chiazza F, Fantozzi R, Bani D, Masini E (2013) Acute treatment with relaxin protects the kidney against ischaemia/re-perfusion injury. J. Cell. Mol. Med. 17: 1494–1505.
  • Cologna AJ, Lima LV, Tucci S Jr, Suaid HJ, Reis RB, Tirapelli LF, Rodrigues AA Jr, Martins AC (2008) Cyclosporine action on kidneys of rats submitted to normothermic ischaemia and re-perfusion. Acta Cir. Bras. 23: 36–41.
  • Dobashi K, Ghosh B, Orak JK, Singh I, Singh AK (2000) Kidney ischemia-re-perfusion: modulation of antioxidant defenses. Mol. Cell. Biochem. 205: 1–11.
  • Du SL, Wang WJ, Wan J, Wang YG, Wang ZK, Zhang Z (2013) Serum salusin-α levels are inversely correlated with the presence and severity of coronary artery disease. Scand. J. Clin. Lab. Invest. 73: 339–343.
  • Erden I, Demir B, Uçak H, Cicek D, Dertlioğlu SB, Aydin S (2014) Serum salusin-α and salusin-β levels in patients with Behcet’s disease. Eur. J. Dermatol. 24: 577–582.
  • Fujimoto K, Hayashi A, Kamata Y, Ogawa A, Watanabe T, Ichikawa R, Iso Y, Koba S, Kobayashi Y, Koyama T, Shichiri M (2013) Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator. PLoS One 8: 76714.
  • Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA (2000) Reactive oxygen species, cell signaling, and cell injury. Free Rad. Biol. Med. 28: 1456–1462.
  • Hong-Xiao Y, Li L, Yan-Xia P, Hong L, Wei-Fang R, Yan L, An-Jing R, Chao-Shu T, Wen-Jun Y (2006) Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J. Cardiovasc. Pharmacol. 48: 41–46.
  • Hsu CY, McCulloch CE, Fan D, Ordonez JD, Chertow GM, Go AS (2007) Community-based incidence of acute renal failure. Kidney Int. 72: 208–212.
  • Izumiyama H, Tanaka H, Egi K, Sunamori M, Hirata Y, Shichiri M (2005) Synthetic salusins as cardiac depressors in rat. Hypertension 45: 419–425.
  • Kimoto S, Sato K, Watanabe T, Suguro T, Koyama T, Shichiri M (2010) Serum levels and urinary excretion of salusin-alpha in renal insufficiency. Regul. Pept. 162: 129–132.
  • Koo DD, Welsh KI, West NE, Channon KM, Penington AJ, Roake JA, Morris PJ, Fuggle SV (2001) Endothelial cell protection against ischemia/re-perfusion injury by lecithinized superoxide dismutase. Kidney Int. 60: 786–796.
  • Koya T, Miyazaki T, Watanabe T, Shichiri M, Atsumi T, Kim-Kaneyama JR, Miyazaki A (2012) Salusin-β accelerates inflammatory responses in vascular endothelial cells via NF-κB signaling in LDL receptor-deficient mice in vivo and HUVECs in vitro. Am. J. Physiol Heart Circ. Physiol. 303: H96–H105.
  • Liu J, Ren YG, Zhang LH, Tong YW, Kang L (2015) Serum salusin-β levels are associated with the presence and severity of coronary artery disease. J. Invest. Med. 63: 632–635.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265–275.
  • Malek M, Nematbakhsh M (2015) Renal ischemia/re-perfusion injury; from pathophysiology to treatment. J. Renal Inj. Prev. 4: 20–27.
  • Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86: 271–278.
  • Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403: 98–103.
  • Nowacek JM, Kiernan JA (2010) Fixation and tissue processing. In: Kumar GL, Kiernan JA, Eds., Guide: Special Stains and H & E, 2nd ed. Dako North America. Carpinteria, CA. pp. 141–152
  • Orrenius S, Zhivotovsky B, Nicotera P (2003) Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell. Biol. 4: 552–565.
  • Ozer Sehirli A, Sener G, Ercan F (2009) Protective effects of pycnogenol against ischemia-re-perfusion induced oxidative renal injury in rats. Ren. Fail. 31: 690–697.
  • Paglia DE, Valentine WN, Dahlgren JG (1975) Effects of low-level lead exposure on pyrimidine 5’-nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5’-nucleotidase in the pathogenesis of lead-induced anemia. J. Clin. Invest. 56: 1164–1169.
  • Paller MS, Hoidal JR, Ferris TF (1984) Oxygen free radicals in ischemic acute renal failure in the rat. J. Clin. Invest. 74: 1156–1164.
  • Roberts BN, Christini DJ (2011) NHE inhibition does not improve Na(+) or Ca(2+) overload during re-perfusion: using modeling to illuminate the mechanisms underlying a therapeutic failure. PLoS Comput. Biol. 7: e1002241.
  • Sahin I, Aydin S (2013) Serum concentration and kidney expression of salusin-α and salusin-β in rats with metabolic syndrome induced by fructose. Biotech. & Histochem. 88: 153–160.
  • Salvadori M, Rosso G, Bertoni E (2015) Update on ischemia-re-perfusion injury in kidney transplantation: pathogenesis and treatment. World J. Transplant. 24: 52–67.
  • Sato K, Koyama T, Tateno T, Hirata Y, Shichiri M (2006) Presence of immunoreactive salusin-α in human serum and urine. Peptides 27: 2561–2566.
  • Sato K, Sato T, Susumu T, Koyama T, Shichiri M (2009) Presence of immunoreactive salusin-beta in human plasma and urine. Regul. Pept. 158: 63–67.
  • Shi JS, Li D, Li N, Lin L, Yang YJ, Tang Y, Sun T, Yuan WJ, Ren AJ (2010) Inhibition of L-type calcium currents by salusin-beta in rat cardiac ventricular myocytes. Peptides 31: 1146–1149.
  • Shichiri M, Ishimaru S, Ota T, Nishikawa T, Isogai T, Hirata Y (2003) Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat. Med. 9: 1166–1172.
  • Suyani E, Derici UB, Sahin T, Ofluoglu E, Pasaoglu H, Erdem O, Barit G, Reis KA, Erten Y, Arinsoy T, Sindel S (2009) Effects of everolimus on cytokines, oxidative stress, and renal histology in ischemia-re-perfusion injury of the kidney. Ren. Fail. 31: 698–703.
  • Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34: 497–500.
  • Suzuki N, Shichiri M, Tateno T, Sato K, Hirata Y (2011) Distinct systemic distribution of salusin-α and salusin-β in the rat. Peptides 32: 805–810.
  • Tanaka T, Nangaku M, Miyata T, Inagi R, Ohse T, Ingelfinger JR, Fujita T (2004) Blockade of calcium influx through L-type calcium channels attenuates mitochondrial injury and apoptosis in hypoxic renal tubular cells. J. Am. Soc. Nephrol. 15: 2320–2333.
  • Thadhani R, Pascual M, Bonventre JV (1996) Acute renal failure. N. Engl. J. Med. 334: 1448–1460.
  • Tuğtepe H, Sener G, Biyikli NK, Yüksel M, Cetinel S, Gedik N, Yeğen BC (2007) The protective effect of oxytocin on renal ischemia/re-perfusion injury in rats. Regul. Pept. 140: 101–118.
  • Tulafu M, Mitaka C, Hnin Si MK, Abe S, Kitagawa M, Ikeda S, Eishi Y, Kurata S, Tomita M (2014) Atrial natriuretic peptide attenuates kidney-lung crosstalk in kidney injury. Surg. Res. 186: 217–225.
  • Wang J, Wang Y, Shan S, Hu T, Chen H, Tian J, Ren A, Zhou X, Yuan W, Lin L (2012) Salusins protect myocardium against ischemic injury by alleviating endoplasmic reticulum stress. Sci. China Life Sci. 55: 358–366.
  • Wang ZS, Liu XH, Wang M, Jiang GJ, Qiu T, Chen ZY, Wang L (2015) Metformin attenuated the inflammation after renal ischemia/re-perfusion and suppressed apoptosis of renal tubular epithelial cell in rats. Acta Cir. Bras. 30: 617–623.
  • Watanabe T, Nishio K, Kanome T, Matsuyama TA, Koba S, Sakai T, Sato K, Hongo S, Nose K, Ota H, Kobayashi Y, Katagiri T, Shichiri M, Miyazaki A (2008) Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation 117: 638–648.
  • Wu D, Chen X, Ding R, Qiao X, Shi S, Xie Y, Hong Q, Feng Z (2008) Ischemia/re-perfusion induce renal tubule apoptosis by inositol 1,4,5-trisphosphate receptor and L-type Ca2+ channel opening. Am. J. Nephrol. 28: 487–499.
  • Xiao-Hong Y, Li L, Yan-Xia P, Hong L, Wei-Fang R, Yan L, An-Jing R, Chao-Shu T, Wen-Jun Y (2006) Salusins protect neonatal rat cardiomyocytes from serum deprivation-induced cell death through upregulation of GRP78. J. Cardiovasc. Pharmacol. 48: 41–46.
  • Yu F, Zhao J, Yang J, Gen B,Wang S, Feng X, Tang C, Chang L (2004) Salusins promote cardiomyocyte growth but does not affect cardiac function in rats. Regul. Pept. 122: 191–197.
  • Zhou CH, Liu LL, Wu YQ, Song Z, Xing SH (2012) Enhanced expression of salusin-β contributes to progression of atherosclerosis in LDL receptor deficient mice. Can. J. Physiol. Pharmacol. 90: 463–471.
  • Zhou CH, Pan J, Huang H, Zhu Y, Zhang M, Liu L, Wu Y (2014) Salusin-β, but not salusin-α, promotes human umbilical vein endothelial cell inflammation via the p38 MAPK/JNK-NF-κB pathway. PLoS One. 11: e107555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.